HealthQuill Pharma
gene editing
Drugs Health Medical Pharma

FDA considering approval for first ever CRISPR gene editing technology drug

HQ Team June 10, 2023:The Food and Drug Administration (FDA) has accepted an application for what could become the first-ever marketed medicine based.

Read More
An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug nirsevimab, meant to treat lower respiratory tract disease in newborns, according to a statement from the Paris-based firm.
Drugs Health Pharma

FDA’s advisory panel backs Sanofi, AstraZeneca’s investigational drug for newborns

HQ Team June 9, 2023: An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug.

Read More
AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to develop cell therapies for treating autoimmune diseases.
Drugs Health Pharma

AstraZeneca signs $2 billion deal for autoimmune diseases

HQ Team June 9, 2023: AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to.

Read More
Researchers at the University of Central Florida have engineered a human tissue that draws mosquitoes to bite and feed on, and hope the platform can help study the pattern of how the pathogens the insects carry impact and infect human cells and tissues.
Drugs Health Pharma

Mosquitoes find engineered human tissue appetizing, boffins target vectors next

HQ Team June 9, 2023: Researchers at the University of Central Florida have engineered a human tissue that draws mosquitoes to bite and.

Read More
The COVID-19 virus can fuse the brain cells that may lead to disruption in cell-to-cell communication resulting in ‘Brain fog,” and loss of sense of odors, researchers at the University of Queensland stated.
Drugs Health Pharma

Fusion of brain cells after COIVID-19 infection may cause ‘brain fog’: Study

HQ Team June 8, 2023: The COVID-19 virus can fuse the brain cells that may lead to disruption in cell-to-cell communication resulting in.

Read More
Global health bodies in more than 100 nations are uniting to vaccinate children after COVID-19 waves severed supplies, shuttered clinics, and overburdened health services.
Drugs Health Pharma

Skin patch shows promise in desensitising toddlers to peanut allergy

HQ Team June 8, 2023: Peanut allergy is a serious health concern and nearly 2 per cent of the Western population suffers from.

Read More
Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority for leqembi, an investigational drug to treat early onset of Alzheimer’s disease.
Drugs Health Medical Pharma

Japan’s Eisai seeks marketing nod for Alzheimer’s drug in South Korea

HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.

Read More
The European Union has announced a 1.23 billion euro initiative to prevent mental health issues and find affordable treatments for its 84 million patients in the bloc.
Drugs Health Medical Pharma

EU unveils €1.2 billion plan to tackle mental health crisis

HQ Team June 8, 2023: The European Union has announced a 1.23 billion euro initiative to prevent mental health issues and find affordable.

Read More
AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the disease, according to a company statement.
Drugs Health Medical Pharma

AstraZeneca’s drug cuts risk of lung cancer death by 51%, trials show

HQ Team June 5, 2023: AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the.

Read More
Drugs Health Medical Pharma

Novartis’ Kisqali shows 25% reduction in breast cancer recurrence

HQ Team June 3, 2023: Novartis breast cancer drug Kisqali cut the risk of recurrence of the disease by more than 25% in.

Read More